Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 33 of 1714:
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43
Gene Compound Assay Inh Ic50 Ki View
dopamine receptor D3 LACIDIPINE Dopamine D3 77% 6.17uM 2.096uM View
adrenergic receptor, alpha 2b RALOXIFENE Adrenergic alpha2C 77% .738uM .107uM View
adrenergic receptor, alpha 2c (Non-specific probe) RALOXIFENE Adrenergic alpha2C 77% .738uM .107uM View
adrenergic receptor, beta 3 CLOMIPHENE Adrenergic beta3 77% 5.673uM 4.254uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 VENLAFAXINE Adrenergic, Norepinephrine Transporter 77% 2.708uM 2.685uM View
cholinergic receptor, muscarinic 2 CLOMIPHENE Muscarinic M2 77% 3.628uM 1.29uM View
Sigma-2 Receptor DROPERIDOL Sigma2 77% 3.283uM 2.02uM View
5-hydroxytryptamine (serotonin) receptor 2B DIPHENHYDRAMINE Serotonin 5-HT2B 77% 1.118uM .711uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DIPHENHYDRAMINE Adrenergic, Norepinephrine Transporter 77% 3.542uM 3.513uM View
Cytochrom P450-1A2 monooxygenase DISULFIRAM CYP450-1A2 Inhibition 77% 4uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) TAMOXIFEN Adrenergic alpha1D 77% 4.982uM 2.449uM View
adrenergic receptor, alpha 2a ERGONOVINE Imidazoline I2, Central 77% 1.843uM 1.228uM View
adrenergic receptor, alpha 2c (Non-specific probe) ERGONOVINE Imidazoline I2, Central 77% 1.843uM 1.228uM View
dopamine receptor D1A ERGONOVINE Dopamine D1 77% 5.901uM 2.95uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CLEMASTINE Adrenergic, Norepinephrine Transporter 77% 3.086uM 3.06uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CLOZAPINE Adrenergic, Norepinephrine Transporter 77% 1.47uM 1.458uM View
leukotriene B4 receptor 2 BENZOTHIAZYL DISULFIDE Leukotriene B4 77% 5.1uM 1.3uM View
leukotriene B4 receptor BENZOTHIAZYL DISULFIDE Leukotriene B4 77% 5.1uM 1.3uM View
leukotriene B4 receptor BENZOTHIAZYL DISULFIDE Leukotriene B4 77% 5.1uM 1.3uM View
leukotriene B4 receptor 2 BENZOTHIAZYL DISULFIDE Leukotriene B4 77% 5.1uM 1.3uM View
cholinergic receptor, muscarinic 1 FLUOXETINE Muscarinic M1 77% 3.203uM .771uM View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
glutamate receptor, ionotropic, NMDA2C DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B DEXTROMETHORPHAN Glutamate, NMDA, Phencyclidine 77% 2.415uM 1.636uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 IPRIFLAVONE Adrenergic, Norepinephrine Transporter 77% 2.5125uM 2.4917uM View
lymphocyte protein tyrosine kinase (mapped) S(-)-CARBIDOPA Protein Tyrosine Kinase, Lck 77% 6.795uM NoneNone View
adrenergic receptor, alpha 2a TRAZODONE Imidazoline I2, Central 77% 2.891uM 1.927uM View
adrenergic receptor, alpha 2c (Non-specific probe) TRAZODONE Imidazoline I2, Central 77% 2.891uM 1.927uM View
5-hydroxytryptamine (serotonin) receptor 1B TRAZODONE Serotonin 5-HT1B 77% 1.356uM .83uM View
cholinergic receptor, muscarinic 3 GENTIAN VIOLET Muscarinic M3 77% 4.33uM .918uM View
sodium channel, nonvoltage-gated 1, delta CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, nonvoltage-gated 1 alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type X, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type IX, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage gated, type VIII, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type VII, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type IV, beta CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type IV, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type III, alpha CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
sodium channel, voltage-gated, type II, beta CITALOPRAM Sodium Channel, Site 2 77% 2.641uM 2.409uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DIPHENHYDRAMINE Calcium Channel Type L, Phenylalkylamine 76% 7.28uM 7.078uM View
5-hydroxytryptamine receptor 6 DISULFIRAM Serotonin 5-HT6 76% 16.001uM 7.429uM View
Sigma-2 Receptor TRIHEXYPHENIDYL Sigma2 76% 3.122uM 1.921uM View
calcium channel, voltage-dependent, beta 3 subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, beta 2 subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, alpha 1F subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, beta 1 subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 8 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
ATPase, Na+/K+ transporting, beta 3 polypeptide CLADRIBINE ATPase, Na+/K+ 13% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 6 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 5 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 4 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 3 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 2 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
calcium channel, voltage-dependent, gamma subunit 1 METHYSERGIDE Calcium Channel Type L, Benzothiazepine 76% 3.559uM 3.164uM View
adrenergic receptor, alpha 2a LEAD (II) ACETATE Adrenergic alpha2A 76% 3.597uM 1.349uM View
5-hydroxytryptamine (serotonin) receptor 2A PROPRANOLOL Serotonin 5-HT2A 76% 1.466uM .419uM View
adrenergic receptor, alpha 2b QUINACRINE Adrenergic alpha2B 76% 1.825uM .833uM View
cholinergic receptor, muscarinic 5 QUINACRINE Muscarinic M5 76% 3.736uM 2.684uM View
histamine receptor H 2 IMIQUIMOD Histamine H2 76% 1.506uM 1.481uM View
adrenergic receptor, alpha 2b SERTRALINE Adrenergic alpha2C 76% 4.477uM .6505uM View
adrenergic receptor, alpha 2c (Non-specific probe) SERTRALINE Adrenergic alpha2C 76% 4.477uM .6505uM View
monoamine oxidase A SELEGILINE Monoamine Oxidase MAOA 76% 2.984uM NoneNone View
monoamine oxidase A SELEGILINE Monoamine Oxidase MAOA 76% 2.984uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B SERTRALINE Serotonin 5-HT2B 76% 3.3935uM 2.1595uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 NORGESTREL Serotonin Transporter 76% 1.119uM .595uM View
prostaglandin-endoperoxide synthase 2 NAPROXEN Cyclooxygenase COX-2 76% 17.001uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) NAPROXEN Cyclooxygenase COX-2 76% 17.001uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 7 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 6 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 5 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 4 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 3 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 2 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, gamma subunit 1 OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, beta 4 subunit OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, beta 3 subunit OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, beta 2 subunit OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, alpha 1F subunit OXICONAZOLE Calcium Channel Type L, Phenylalkylamine 76% 2.7269uM 2.6512uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
calcium channel, voltage-dependent, beta 1 subunit SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
calcium channel, voltage-dependent, gamma subunit 8 SIBUTRAMINE Calcium Channel Type L, Benzothiazepine 75% .809uM .719uM View
adrenergic receptor, beta 3 CANDESARTAN Adrenergic beta3 75% 4.3uM 3.2uM View
Cytochrom P450-1A2 monooxygenase ARTEMISININ CYP450-1A2 Inhibition 75% 2uM NoneNone View
adrenergic receptor, alpha 2b DAPIPRAZOLE Adrenergic alpha2B 75% 1.153uM .526uM View
phosphodiesterase 4A, cAMP specific SB-203580 Phosphodiesterase PDE4 75% 11.59uM NoneNone View
phosphodiesterase 4C, cAMP-specific SB-203580 Phosphodiesterase PDE4 75% 11.59uM NoneNone View
phosphodiesterase 4D SB-203580 Phosphodiesterase PDE4 75% 11.59uM NoneNone View
phosphodiesterase 4B, cAMP specific SB-203580 Phosphodiesterase PDE4 75% 11.59uM NoneNone View
sodium channel, nonvoltage-gated 1 beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type XI, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1, gamma NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1, delta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1 alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type X, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IX, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage gated, type VIII, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type VII, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IV, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IV, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type III, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type II, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type II, alpha 2 NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type I, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type I, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IV, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel associated protein 1 NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel associated protein 2 NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type III, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type I, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IX, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type VII, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
amiloride-sensitive cation channel 5, intestinal NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type III, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type XI, alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type I, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type 10, alpha polypeptide NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type IV, alpha polypeptide NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type V, alpha polypeptide NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, voltage-gated, type II, beta NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1 alpha NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
sodium channel, nonvoltage-gated 1 gamma NISOLDIPINE Sodium Channel, Site 2 75% 7.354uM 6.709uM View
calcium channel, voltage-dependent, gamma subunit 8 CLOMIPHENE Calcium Channel Type L, Dihydropyridine 75% 1.62uM 1.041uM View
calcium channel, voltage-dependent, gamma subunit 7 CLOMIPHENE Calcium Channel Type L, Dihydropyridine 75% 1.62uM 1.041uM View
calcium channel, voltage-dependent, alpha 1F subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, beta 1 subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
melanocortin 5 receptor SERTRALINE Melanocortin MC5 74% 4.598uM 4.3132uM View
calcium channel, voltage-dependent, gamma subunit 8 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, gamma subunit 7 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
calcium channel, voltage-dependent, gamma subunit 6 SERTRALINE Calcium Channel Type L, Benzothiazepine 74% 1.468uM 1.3049uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, gamma 1 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, pi NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
AT hook, DNA binding motif, containing 1 (DBSS) NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, theta NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, gamma 2 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, alpha 2 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, alpha 1 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid A receptor, delta NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 NORGESTREL GABAA, Benzodiazepine, Central 74% 2.359uM 1.922uM View
prostaglandin-endoperoxide synthase 1 NIFLUMIC ACID Cyclooxygenase COX-1 74% 1.064uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) NIFLUMIC ACID Cyclooxygenase COX-1 74% 1.064uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) OXYMETAZOLINE Adrenergic alpha1D 74% 2.844uM 1.398uM View
adrenergic receptor, alpha 2a ORPHENADRINE Adrenergic alpha2A 74% 2.156uM .809uM View
adrenergic receptor, alpha 2a CADMIUM CHLORIDE Adrenergic alpha2A 74% 6.918uM 2.594uM View
tachykinin receptor 2 CETYLPYRIDINIUM BROMIDE Tachykinin NK2 74% 8.632uM 2.877uM View
androgen receptor CLOBETASOL PROPIONATE Testosterone 74% 3.775uM 2.517uM View
mitogen activated protein kinase 1 SULFASALAZINE Protein Serine/Threonine Kinase, ERK2 74% 6.332uM NoneNone View
mitogen-activated protein kinase 1 SULFASALAZINE Protein Serine/Threonine Kinase, ERK2 74% 6.332uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B DROPERIDOL Serotonin 5-HT4 74% 3.789uM .632uM View
5-hydroxytryptamine (serotonin) receptor 4 DROPERIDOL Serotonin 5-HT4 74% 3.789uM .632uM View
phosphodiesterase 4C, cAMP-specific DIPYRIDAMOLE Phosphodiesterase PDE4 74% 1.579uM NoneNone View
phosphodiesterase 4D DIPYRIDAMOLE Phosphodiesterase PDE4 74% 1.579uM NoneNone View
phosphodiesterase 4B, cAMP specific DIPYRIDAMOLE Phosphodiesterase PDE4 74% 1.579uM NoneNone View
chemokine (C-C motif) receptor 2 BENZOTHIAZYL DISULFIDE Chemokine CCR2B 74% 2.405uM .929uM View
5-hydroxytryptamine receptor 6 FLUOXETINE Serotonin 5-HT6 74% 1.661uM .771uM View
adrenergic receptor, alpha 2a DOXEPIN Imidazoline I2, Central 74% 1.839uM 1.226uM View
adrenergic receptor, alpha 2c (Non-specific probe) DOXEPIN Imidazoline I2, Central 74% 1.839uM 1.226uM View
sodium channel, voltage-gated, type IV, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel associated protein 1 DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel associated protein 2 DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type III, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type I, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type IX, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type VII, alpha DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
amiloride-sensitive cation channel 5, intestinal DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type III, beta DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DOXEPIN Sodium Channel, Site 2 74% 2.542uM 2.319uM View